- Joined
- Apr 12, 2009
- Messages
- 2,097
- Reaction score
- 1
- Points
- 1
- Pharmacist
Advertisement - Members don't see this ad
You mean the one where it was compared to imipenem and if/when pseudomonas was a concern the tigecycline arm was given the mighty aztreonam and if MRSA was a concern the imipenem arm was given vanco?
Took you long enough to google that. Yup look at the MRSA arm.
And bacteremia does play a huge role as usually the serum levels of tigecycline is below most gm- MICs and usually only the peak level is above the MIC for gm+.
In your mind maybe. But where are the bugs in pneumonia? Typicals vs. Atypicals. Better yet where are the MRSA and can Tygacil get there?
EDIT: would never use tigecycline in a real patient unless no other option and while it seems like i'm "defending" tigecycline, I'm not like a employee of wyeth or pfizer or whoever owns it now, just speaking in the hypothetical realm of SDN.
Then stop playing devil's advocate while making little sense.